Cresco Labs Inc.
Cresco Labs Inc. (CL.CN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cl.cn · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Cresco Labs Inc. (CL.CN) measures how much investors pay for each dollar of the company's trailing earnings. CL.CN's current PE ratio of N/A is calculated by dividing its stock price of $1.33 by its TTM earnings per share of -$0.38.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2007 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Cresco Labs Inc.You CL.CN | $471M | N/A | — | -$0.38 |
 Aurora Cannabis Inc. ACB.TO | $271M | 217.30x | +91.2% | $0.03 |
 Cipher Pharmaceuticals Inc. CPH.TO | $429M | 10.05x | -91.2% | $1.09 |
 Bright Minds Biosciences Inc. DRUG.CN | $695M | N/A | — | -$1.78 |
 Knight Therapeutics Inc. GUD.TO | $896M | N/A | — | -$0.05 |
 MariMed Inc. MRMD.CN | $40M | N/A | — | -$0.04 |
 OrganiGram Holdings Inc. OGI.TO | $206M | N/A | — | -$0.19 |
Industry Average 2 peers with valid PE | — | 113.68x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.40 | — | |
2024-12-31 FY2024 | — | $-0.22 | — | |
2023-12-31 FY2023 | — | $-0.54 | — | |
2022-12-31 FY2022 | — | $-0.71 | — | |
2021-12-31 FY2021 | — | $-1.22 | — | |
2020-12-31 FY2020 | — | $-0.49 | — | |
2019-12-31 FY2019 | — | $-0.37 | — | |
2018-12-31 FY2018 | — | $-0.03 | — | |
2018-01-31 FY2018 | — | $-0.00 | — | |
2017-01-31 FY2017 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Cresco Labs Inc. (CL.CN) measures how much investors pay for each dollar of the company's trailing earnings. CL.CN's current PE ratio of N/A is calculated by dividing its stock price of $1.33 by its TTM earnings per share of -$0.38.
Frequently asked questions
CL.CN pe ratio · 6 questionsCL.CN's current PE ratio is N/A as of 2026-06-08, based on a stock price of $1.33 and TTM EPS of -$0.38. Data sourced from Financial Modeling Prep via CL.CN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cresco Labs Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08